Please login to the form below

Not currently logged in
UK payer perspectives: Is big data the future of market access?

Big Data is big business. As technology advances and more information about healthcare is recorded and stored, the opportunities for turning information into insight to improve outcomes have never been greater. It is no surprise that it is those most able to collect and, crucially, interpret this data who are pushing the boundaries of what is possible in market access. In the new health economies, biopharma needs to work much harder to meet the demands of stakeholders for robust evidence of exactly how a product will lead to better patient outcomes in the real world. Compelling data lies at the very heart of this challenge.

What do payers and providers want to see from Big Data? Where are the gaps, and how can the information be better manipulated and localized? Should we be expanding our frame of reference, moving from PROMS and PREMS, and delving more into quality of life? Do we need a shift in focus towards non-health specific lifestyle data sets so we can understand not just the clinical impact of a drug on a patient, but how that patient's exercise levels and diet, for example, are affecting outcomes? 

These questions will be tackled on 5 November at 2pm (GMT), PMLiVE, in association with Quintiles, will be hosting a free webinar to examine exactly how big data can play a role in the future of market access, and discuss how big data can improve real world outcomes. 

'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP and board member for Greenwich CCG.

The webinar and Q and A is free, so register now to watch it live on the day or access the recorded version at a later date.

Dr Junaid Bajwa
Dr Junaid Bajwa, a GP and board member for Greenwich CCG
Dr Bajwa is also a Council Member for the London Clinical Senate and, since June 2014, has been seconded to the NHS Leadership Academy as part of their Fast Track Executive Programme.
Paul Sutton
Paul Sutton, director of outcomes and value at Quintiles Commercial UK
Paul Sutton leads the design and implementation of health informatics, data analytics, service pathway evaluation and modeling, and patient outcome audit service: to help pharmaceutical clients (and their NHS stakeholders) understand, realize and demonstrate real-world outcomes and value for their brands at a local health economy level in the UK market.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Nucleus Global

Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 700 experts delivering world-class...

Latest intelligence

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021....
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs....
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial...